Skip to main content
Top
Published in: Diabetologia 5/2007

01-05-2007 | Article

Improved survival rate in patients with diabetes and end-stage renal disease in Denmark

Authors: V. R. Sørensen, E. R. Mathiesen, J. Heaf, B. Feldt-Rasmussen

Published in: Diabetologia | Issue 5/2007

Login to get access

Abstract

Aims/hypothesis

We investigated the survival rate of Danish diabetic patients with end-stage renal disease (ESRD) between 1990 and 2005 and evaluated possible predictors of survival rate.

Materials and methods

Data were obtained from the Danish National Register on Dialysis and Transplantation and from the Scandiatransplant database. Survival rates in different patient groups and association with age, sex, calendar time, waiting-list status and renal transplantation were evaluated using a multivariate Cox regression model.

Results

During the study period 8,421 patients (13% type 1 diabetic, 9% type 2 diabetic and 78% non-diabetic) started renal replacement therapy. The overall survival rate improved by 15% per five calendar years (hazard ratio [HR]=0.85, 95% CI: 0.81–0.88). The percentage of patients within each group who received renal transplantation was: type 1 diabetic: 26%, type 2 diabetic: 5%, non-diabetic: 24%. The survival rate of transplanted patients with diabetes mellitus (types 1 and 2) compared with non-diabetic patients at 1 year was: 95 vs 93%, at 5 years: 80 vs 85% and at 10 years: 52 vs 71%. Among diabetic patients survival rate was better in transplanted than in waiting-list patients (HR = 0.21, 95% CI 0.13–0.34), whereas the survival rate in waiting-list patients seemed to be superior to the survival rate among non-transplantation candidates (HR = 0.75, 95% CI 0.53–0.1.02, p = 0.07).

Conclusions/interpretation

The survival rate of diabetic patients with ESRD has improved during the last 15 years. Although some selection bias may exist, significantly improved survival rate was observed among transplanted patients compared with dialysis patients on the waiting-list for transplantation. Renal transplantation should therefore be offered to diabetic patients with ESRD whenever possible.
Literature
1.
go back to reference The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
2.
go back to reference UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef
3.
go back to reference Adler AI, Stratton IM, Neil HA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 321:412–419CrossRef Adler AI, Stratton IM, Neil HA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 321:412–419CrossRef
4.
go back to reference Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869PubMedCrossRef Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869PubMedCrossRef
5.
go back to reference Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016PubMedCrossRef Collins R, Armitage J, Parish S, Sleigh P, Peto R (2003) MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016PubMedCrossRef
6.
go back to reference Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617–622PubMedCrossRef Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617–622PubMedCrossRef
7.
go back to reference Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870–878PubMedCrossRef Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870–878PubMedCrossRef
8.
go back to reference The Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes control and complications trial. Kidney Int 47:1703–1720 The Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes control and complications trial. Kidney Int 47:1703–1720
9.
go back to reference Sorensen VR, Hansen PM, Heaf J, Feldt-Rasmussen B (2006) Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark. Kidney Int 70:187–191PubMedCrossRef Sorensen VR, Hansen PM, Heaf J, Feldt-Rasmussen B (2006) Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark. Kidney Int 70:187–191PubMedCrossRef
10.
go back to reference Gaylin DS, Held PJ, Port FK et al (1993) The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 269:603–608PubMedCrossRef Gaylin DS, Held PJ, Port FK et al (1993) The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA 269:603–608PubMedCrossRef
11.
go back to reference Satayathum S, Pisoni RL, McCullough KP et al (2005) Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 68:330–337PubMedCrossRef Satayathum S, Pisoni RL, McCullough KP et al (2005) Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 68:330–337PubMedCrossRef
12.
go back to reference Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730PubMedCrossRef Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730PubMedCrossRef
13.
go back to reference Locatelli F, Pozzoni P, Del Vecchio L (2004) Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 15(Suppl 1):S25–S29PubMedCrossRef Locatelli F, Pozzoni P, Del Vecchio L (2004) Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 15(Suppl 1):S25–S29PubMedCrossRef
14.
go back to reference Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B (2001) Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 12:1293–1296PubMed Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B (2001) Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 12:1293–1296PubMed
15.
go back to reference Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612PubMedCrossRef Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612PubMedCrossRef
16.
go back to reference Rao PS, Schaubel DE, Saran R (2005) Impact of graft failure on patient survival on dialysis: a comparison of transplant-naive and post-graft failure mortality rates. Nephrol Dial Transplant 20:387–391PubMedCrossRef Rao PS, Schaubel DE, Saran R (2005) Impact of graft failure on patient survival on dialysis: a comparison of transplant-naive and post-graft failure mortality rates. Nephrol Dial Transplant 20:387–391PubMedCrossRef
17.
go back to reference Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis HP, Parving HH (2005) Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 68:1250–1257PubMedCrossRef Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis HP, Parving HH (2005) Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 68:1250–1257PubMedCrossRef
18.
go back to reference Schon S, Ekberg H, Wikstrom B, Oden A, Ahlmen J (2004) Renal replacement therapy in Sweden. Scand J Urol Nephrol 38:332–339PubMedCrossRef Schon S, Ekberg H, Wikstrom B, Oden A, Ahlmen J (2004) Renal replacement therapy in Sweden. Scand J Urol Nephrol 38:332–339PubMedCrossRef
19.
go back to reference Lufft V, Dannenberg B, Schlitt HJ, Pichlmayr R, Brunkhorst R (2004) Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: a case-control study. Clin Nephrol 61:238–245PubMed Lufft V, Dannenberg B, Schlitt HJ, Pichlmayr R, Brunkhorst R (2004) Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: a case-control study. Clin Nephrol 61:238–245PubMed
20.
go back to reference Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM (2001) Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 15:89–94PubMedCrossRef Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM (2001) Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant 15:89–94PubMedCrossRef
21.
go back to reference Bittar J, Cepeda P, de la Fuente J, Douthat W, de Arteaga J, Massari PU (2006) Renal transplantation in diabetic patients. Transplant Proc 38:895–898PubMedCrossRef Bittar J, Cepeda P, de la Fuente J, Douthat W, de Arteaga J, Massari PU (2006) Renal transplantation in diabetic patients. Transplant Proc 38:895–898PubMedCrossRef
22.
go back to reference Ekberg H, Christensson A (1996) Similar treatment success rate after renal transplantation in diabetic and nondiabetic patients due to improved short- and long-term diabetic patient survival. Transpl Int 9:557–564PubMedCrossRef Ekberg H, Christensson A (1996) Similar treatment success rate after renal transplantation in diabetic and nondiabetic patients due to improved short- and long-term diabetic patient survival. Transpl Int 9:557–564PubMedCrossRef
23.
go back to reference Romming SV, Schwartz SS, Feldt-Rasmussen B (2006) Long-term graft and patient survival following renal transplantation in diabetic patients. Scand J Urol Nephrol 40:247–251CrossRef Romming SV, Schwartz SS, Feldt-Rasmussen B (2006) Long-term graft and patient survival following renal transplantation in diabetic patients. Scand J Urol Nephrol 40:247–251CrossRef
24.
go back to reference Brunkhorst R, Lufft V, Dannenberg B, Kliem V, Tusch G, Pichlmayr R (2003) Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study. Transplantation 76:115–119PubMedCrossRef Brunkhorst R, Lufft V, Dannenberg B, Kliem V, Tusch G, Pichlmayr R (2003) Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case-control study. Transplantation 76:115–119PubMedCrossRef
Metadata
Title
Improved survival rate in patients with diabetes and end-stage renal disease in Denmark
Authors
V. R. Sørensen
E. R. Mathiesen
J. Heaf
B. Feldt-Rasmussen
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0612-5

Other articles of this Issue 5/2007

Diabetologia 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.